Stock RPHM RENEO PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Reneo Pharmaceuticals, Inc.

Equities

RPHM

US75974E1038

Real-time Estimate Cboe BZX
Other stock markets
 10:31:29 2024-06-10 am EDT 		5-day change 1st Jan Change
1.67 USD 0.00% Intraday chart for Reneo Pharmaceuticals, Inc. 0.00% +4.38%
May. 16 Reneo Pharmaceuticals Insider Bought Shares Worth $639,578, According to a Recent SEC Filing MT
May. 13 Reneo Pharmaceuticals to Merge With OnKure in All-Stock Deal -- Reneo Shares Rise MT

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
RENEO PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Reneo Pharmaceuticals, Inc. - RPHM
BU
STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Announces An Investigation of Reneo Pharmaceuticals, Inc. - RPHM
PR
Shareholder Alert: Ademi LLP investigates whether Reneo Pharmaceuticals, Inc. has obtained a Fair Price in its Transaction with OnKure
PR
RPHM Alert: Monsey Firm of Wohl & Fruchter Investigating Proposed Merger of Reneo Pharmaceuticals With OnKure
AQ
RPHM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Reneo Pharmaceuticals, Inc. Is Fair to Shareholders
BU
Reneo Pharmaceuticals and OnKure Announce Proposed Merger
GL
Reneo Pharmaceuticals Reports First Quarter 2024 Financial Results
GL
Reneo Pharmaceuticals Reports Fourth Quarter And Full Year 2023 Financial Results And Business Update
GL
Reneo Pharmaceuticals Announces Results from Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM)
GL
Reneo Pharmaceuticals Announces Results from Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM)
AQ
Reneo Pharmaceuticals Reports Third Quarter 2023 Financial Results
GL
Reneo Pharmaceuticals to Participate in Upcoming Investor Conferences
GL
Reneo Pharmaceuticals to Participate in Upcoming Investor Conferences
AQ
Women in Stem with Ashley Hall
AQ
Reneo Pharmaceuticals Announces Poster Presentation at Upcoming Scientific Meetings
GL
Reneo Pharmaceuticals Announces Poster Presentation at Upcoming Scientific Meetings
AQ
Reneo Pharmaceuticals Announces Last Patient Last Visit in the Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM)
GL
Reneo Pharmaceuticals Announces Last Patient Last Visit in the Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM)
AQ
Reneo Pharmaceuticals to Participate in the Jefferies Biotech CNS/Neuro Summit
GL
Reneo Pharmaceuticals to Participate in Upcoming Investor Conferences
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. RPHM Stock
  4. News Reneo Pharmaceuticals, Inc.
  5. Press Releases